Barclays raised a price target and Cantor Fitzgerald reiterated an Overweight rating on Tenet Healthcare.
4 reports, 2 independent
Updated Aug 1
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays raised a price target and Cantor Fitzgerald reiterated an Overweight rating on Tenet Healthcare.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Rating firms Barclays and Cantor Fitzgerald updated their outlook on Robinhood Markets Inc.1 source
Barclays and Cantor Fitzgerald issued rating updates on Tenet Healthcare stock.1 source
Keep exploring
The entities involved
-
Tenet Healthcare
American healthcare company
-
Barclays
British bank
- QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.
- Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.
-
Cantor Fitzgerald
American financial services company
Related events
- Barclays maintained Overweight rating and raised price target on August 29, 2025.
- Cantor Fitzgerald reiterated an Overweight rating on Amazon stock.
- Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.
- Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.
- Cantor Fitzgerald, Morgan Stanley, and Royal Bank of Canada issued price target updates for Elevance Health, Inc. on September 12, 2026.